Abstract. To better define the role of carbohydrate in the structure and ristocetin cofactor activity of von Willebrand factor, we have removed up to 83% of total hexose by sequential treatment of the molecule with endo-#-N-acetyl-glucosaminidase F (endo F), neur- 
Introduction
von Willebrand Factor (vWF)' is a large multimeric glycoprotein that interacts with platelets at the early stages of hemostasis.
1. Abbreviations used in this paper: EACA, E-amino caproic acid; endo F, endo-,-N-acetyl-glucosaminidase F; TBS, Tris-buffered saline; vWF, von Willebrand factor; eF-vWF, vWF modified by endo F; neu-vWF, vWF modified by neuraminidase; neu-#-gal-vWF, vWF modified by neuraminidase and ,B-galactosidase sequentially; ef-neu-vWF, vWF modified by endo F and neuraminidase sequentially; eF-neu-#-galvWF, vWF modified by endo F, neuraminidase, and ,B-galactosidase sequentially.
The largest vWF multimers appear to be the most hemostatically effective and are absent in some variants of von Willebrand disease (1) (2) (3) (4) . Carbohydrate composes 10-15% of the mass of vWF and has been implicated in the structural and functional integrity of the molecule (1) . The structure of the major asparagine-linked sugar chain of vWF has been determined (5) . The removal of terminal sialic acid with neuraminidase has been reported to result in loss of ristocetin cofactor activity by some authors (6, 7) , while other investigators have found no changes of this activity (8, 9) . Rather, asialo-vWF induces spontaneous aggregation of platelets in the presence of one or more plasma cofactors (8) . Removal of the penultimate galactose by fl-galactosidase or its modification by galactose-oxidase has been reported to largely abolish the ristocetin cofactor activity of vWF (9, 10) . More recently, removal of galactose residues has also been associated with loss of large vWF multimers (I 1). Carbohydrate analysis of vWF from patients with von Willebrand disease has shown decreased sugar content in some individuals (8, 12, 13) , but not in others (8, 14) .
We have treated vWF sequentially with endo-fl-N-acetylglucosaminidase F (endo F) (15) , neuraminidase, and l-galactosidase, and were able to remove as much as 83% of the carbohydrate from the molecule. However, we could not confirm that carbohydrate was necessary for either the ristocetin cofactor activity of vWF or its multimeric structure. Rather we demonstrated that carbohydrate protects vWF against plasmin degradation. The role of the carbohydrate side chain in protecting glycoproteins from proteolytic degradation has been observed previously (16) and may be of importance in maintaining the integrity of vWF in an environment where proteases, such as plasmin, may be present.
Methods
vWF protein was purified from cryoprecipitate, kindly provided by Dr. Carolyn Orthner (American Red Cross, Bethesda, MD). This material was recryoprecipitated after the addition of 20 mM E-aminocaproic acid (EACA) and processed according to the method of Newman et al. (17) , as modified by Switzer and McKee (18) . After the final polyethylene glycol precipitation, sucrose (20% wt/vol) was added and ultracentrifugation was performed at 100,000 g for 45 min. The lipid was removed by aspiration and the remaining supernatant was then passed through a 90 X 5-cm Sepharose CL4B (Pharmacia Fine Chemicals, Piscataway, NJ) column equilibrated with 0.02 M imidazol, 0.01 M citrate, 0.02 M EACA, 0.15 M NaCI, pH 6.5. Fractions of the first two-thirds of the void volume were pooled and concentrated to 1-4 mg/ml in dialysis bags using Aquacide II After incubation with the enzymes, vWF was passed through a 15 X 0.5-cm Sepharose CL-4B column equilibrated with TBS. Control native vWF was similarly treated. Void volume fractions were pooled and analyzed within 24 h for carbohydrate content, ristocetin cofactor activity, and mobility in both unreduced SDS-agarose gels and reduced SDS-polyacrylamide gels. The recovery of vWF in the void volume fractions was always between 50 and 70%. In some experiments, the carbohydrate present in the included fractions was measured to demonstrate that carbohydrate removed from vWF could be recovered.
In some experiments, vWF was subsequently incubated with plasmin in concentrations of 4 to 96 Ag/mg of vWF for 4-24 h at 37°C. After incubation, plasmin was neutralized with aprotonin (20-50 U/ml). Total hexose content of vWF was measured by the phenol sulphuric method of Dubois et al. (20) , using a 1:1 mixture of glucose and galactose or a 1:1 mixture of mannose and galactose as reference standards. Both standards gave similar results. N-Acetyl glucosamine was determined in a Beckman (Beckman Instruments, Fullerton, CA) amino acid analyzer 121-M after hydrolysis in 5.7 N HC1 at 1 10°C for 4 h, using pure N-acetyl glucosamine as reference. Sialic acid was measured after hydrolysis of vWF in 0.02 M H2SO4 at 80°C for 60 min using N-acetylneuraminic acid as a standard (21) . D-Galactose and L-Fucose were determined after hydrolysis in I or 2 M hydrochloric acid at 1000C for 2 h by an enzymatic assay using galactose-and fucose-dehydrogenase respectively. No differences were seen at the different hydrochloric acid concentrations (22) .
Protein concentration was determined either by the method of Lowry et al. (23) or by absorbance at 280 nm, using a scattering correction based on the absorbance at 320 nm (18 (26) except that formalin fixed platelets were used. vWF antigen levels were analyzed by rocket immunoelectrophoresis (27) . In both assays results were expressed as a percent of a pool of 20 normal plasmas.
Results
Carbohydrate content after enzymatic treatment. Endo F removes carbohydrate most efficiently with the aid of detergents and reducing agents (15) . However, for our studies, we wished to maintain as much native structure as possible and thus such agents were not used. Therefore, relatively large quantities of enzyme were required. To determine the maximum amount of carbohydrate that could be removed with endo F, increasing concentrations of the enzyme were incubated with a constant concentration of vWF. At 50 U endo F/mg of vWF, maximal removal of hexose, sialic acid, and D-galactose was achieved. For all succeeding experiments, this concentration of endo F was, therefore, used. Approximately 69% of total hexose was removed from endo F-treated vWF (eF-vWF) (Tables I and  II) , as were corresponding amounts of N-acetyl glucosamine, sialic acid and D-galactose (Tables I and II) . However, there was only a minimal decrease in the content of L-fucose (Tables  I and II) (Tables I and II) .
Native vWF was also treated with neuraminidase (neuvWF), then followed by fl-galactosidase (neu-j#-gal-vWF). In four experiments, this resulted in an average reduction of sialic acid to 5%, D-galactose to 28%, and total hexose to 68% of the initial concentrations (Tables I and II showed increased electrophoretic mobility when compared with native vWF. This was even greater if the vWF was first treated with endo F. Endo F alone had a similar effect (not shown). However, no apparent changes in the triplet structure nor evident loss of the largest multimers occurred after removal of carbohydrate. Purified native vWF had the same multimeric structure as vWF in plasma (not shown).
Ristocetin cofactor activity per unit of vWF antigens was determined for the different forms of carbohydrate modified vWF (Table III) . eF-vWF showed 89% of initial activity, while eF-neu-vWF and eF-neu-(#-gal-vWF had 70 and 57%, respectively. Ristocetin cofactor activity of neu-vWF was higher than that of native vWF (111%), while that of neu-#-gal-vWF was 62%. However, neu-,B-gal-vWF prepared in the presence of benzamidine, leupeptin, and aprotonin retained 99% of ristocetin cofactor activity, though the reduction in carbohydrate was as great as in the absence of these protease inhibitors (Tables I, II, and III) .
Effect of plasmin on carbohydrate modified vWF. Carbohydrate modified vWF, but not native vWF, readily lost large multimers consequent to plasmin proteolysis. This was evident with neu-vWF, but even more so with neu-ft-gal-vWF (Fig. 3) .
As little as 4 Mg plasmin/mg of vWF produced appreciable large multimer loss from neu-p-gal-vWF in 16 h (Fig. 4) . This effect was dose dependent (Fig. 4) . On the other hand, only minimal loss of large multimers from native vWF could be detected with 96 Mg of plasmin per mg of vWF after 24 h (not shown). from the molecule. In our hands, neuraminidase and neuraminidase followed by f3-galactosidase removed similar percentages of sialic acid and D-galactose as previously reported by others (9, 10) . In contrast to the recent report of Gralnik and co-workers (10), however, no discernible alteration of multimeric structure was observed after this treatment. Though exoglycosidase treatment of vWF in the absence of protease inhibitors was followed by a decrease in ristocetin cofactor activity to -62% of the initial value, no decrease was seen when these inhibitors were present throughout the incubation. Nevertheless, the decrease in total hexose and galactose was the same in both cases. with neuraminidase followed by fl-galactosidase or galactose-oxidase. The explanation of these different results may lie in the demonstration that small quantities of plasmin induce loss of large multimers from carbohydrate modified vWF. Since traces of one or more proteases may contaminate even highly purified vWF, removal of carbohydrate may appear to be directly responsible for causing disaggregation of vWF when it is simply making the protein susceptible to attack by plasmin or other contaminating proteases. Disaggregation from any cause can be expected to decrease ristocetin cofactor activity. Though not readily apparent on SDS-agarose electrophoresis, some disaggregation may have occurred and caused the partial loss of ristocetin cofactor activity we observed in those of our experiments performed in the absence of protease inhibitors.
The physiological significance of the carbohydrate moiety of most glycoproteins is not known. Recently, however, carbohydrate has been shown to protect proteins from intracellular and extracellular proteolytic degradation (16) . Our results demonstrate that this is clearly one role of the carbohydrate moiety of vWF. It may be particularly important in situations, such as intravascular coagulation, when free proteases may appear in plasma and degradation of vWF would significantly worsen an already compromised hemostatic mechanism.
Treatment of vWF with endo F removed -69% of total hexose and of D-galactose. This was associated with an alteration in the migration rate of the reduced subunit in SDS-polyacrylamide gels consistent with a decrease in molecular mass of approximately 10%. Since all of the vWF subunit changed its migration rate after treatment, it is unlikely that carbohydrate was removed from only a subset of vWF molecules. In addition, all of the multimers of unreduced vWF showed a more rapid migration in SDS-agarose after treatment with endo F. However, there was no discernible loss of large multimers and the ristocetin cofactor activity was decreased only 11%. This again contrasts with the report of Gralnick and co-workers in which release of 60% of the D-galactose was associated with a readily demonstrable loss of large multimers and a 70% decrease in ristocetin cofactor activity.
Treatment of eF-vWF with neuraminidase and ,B-galactosidase succeeded in reducing the total hexose to only 17% of that in native vWF. Despite this marked reduction in sugar content, the larger multimers remained intact and the "triplet structure" of repeating multimeric units was not altered. These observations have important implications, with regard to the proposed role of carbohydrate in determining some of the abnormalities seen in von Willebrand disease (10) . In a previous report we showed that the vWF in types I, IIA, and IUb von Willebrand disease had a normal or decreased isoelectric point (29) . On the contrary, neuraminidase-treated vWF had a substantially higher isoelectric point than normal vWF (28) , as would be expected following removal of the negatively charged sialic acid residues. It was, therefore, unlikely that simple absence of sialic acid was the basis for the vWF abnormalities seen in the von Willebrand disease variants studied. However, a more profound defect in the carbohydrate structure of vWF-with balancing effects on the isoelectric point-could not be excluded on the basis of those studies. The current results, however, are not consistent with the latter possibility. First, the multimeric structure of eF-neu-(#-galvWF is intact with only 17% of the total hexose remaining. Moreover, removal of 69% of the total hexose with endo F alone resulted in more rapid migration of all of the multimers without changing their triplet structure. Such an alteration in migration rate of individual multimers has not yet been seen in von Willebrand disease, including those variants in which the large multimers are lacking. Even those rare variants in which the triplet pattern is disordered do not show the changes seen here (30, 31) . Though these considerations cannot exclude a subtle abnormality of carbohydrate in von Willebrand disease, they make a global disorder unlikely.
